RxDoctor Payments Data

Anne Paden

Psychiatric/Mental Health · Wappingers Falls, NYNPI 1275509879

Payments from drug & device makers

$5,272in general payments, 2019–2025

Across 243 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Axsome Therapeutics, Inc.$712
  • Lundbeck LLC$404
  • Teva Pharmaceuticals USA, Inc.$337
  • Jazz Pharmaceuticals Inc.$320
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$263
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$5,12997%
  • Education$1433%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,272 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$46,777
Medicare patients
122
Services billed
624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole21$32,886
VraylarCariprazine Hcl14$19,113
TrintellixVortioxetine Hydrobromide16$8,530
Adderall XrDextroamphetamine/Amphetamine22$6,481
CymbaltaDuloxetine Hcl11$5,776
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine171$4,273
Ziprasidone Hcl18$4,122
Aripiprazole67$3,062
Bupropion XlBupropion Hcl87$2,416
Methylphenidate Er (La)Methylphenidate Hcl19$2,364
Clonazepam266$2,193
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$2,055
Lorazepam178$1,893
Methylphenidate Hcl53$1,656
Alprazolam257$1,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$110$32,88621 claims
AbbVieVraylar$2,083$19,11314 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$146$8,53016 claims
Almatica Pharma LLCSertraline Hcl$28$57574 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Wappingers Falls

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →